Clinical Trial Update: AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing AK112 plus chemotherapy to Durvalumab plus chemotherapy in advanced biliary tract cancer; the trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• AK112
• Durvalumab (durvalumab)

Snippet

Sponsor: Akeso | Conditions: Biliary Tract Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING